GENE ONLINE|News &
Opinion
Blog

Asthma
Asthma Medications: From Quick Relief to Long-Term Control
2024-03-11
GSK Completed the Acquisition of Aiolos Bio, Enhancing the Respiratory Portfolio of Asthma
2024-02-16
AstraZeneca’s severe asthma drug Tezspire has been granted market authorization in South Korea
2023-12-25
Have A Good Night’s Sleep To Cut Asthma Risk
2023-04-17
Novartis, Genentech Bag Key FDA Okay for Blockbuster Drug
2021-04-14
Amgen and AstraZeneca’s Asthma Drug Flunks Phase 3 Trial
2020-12-26
Kinaset Therapeutics Debuts in the Asthma Market with $40 Million Financing
2020-12-02
Amgen, AstraZeneca’s Tezepelumab Impresses in Phase 3 Asthma Trial
2020-11-11
Can Your Smartwatch Help You Manage Asthma Better?
2020-09-19
Japan Trials Asthma Drug Alvesco to fight COVID-19
2020-03-29
Astra Zeneca to Resume Rivalry with Old Competitor Following Key Win for FASENRA®
2019-10-14
Novartis Reports Trial Successes of its Asthma Drugs that Holds Potential Edge Over Longstanding Market Leader
2019-10-04
Novartis’s Ligelizumab Progresses to Phase III Trial
2018-12-17
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top